Analysis assesses suicide prevention benefit of lithium drugs

06/27/2013 | HealthDay News

Researchers examined data from 48 trials that included more than 6,600 people with mood disorders and found that patients treated with lithium had a 60% lower risk of suicide than those who took a placebo. Those who took lithium were also less likely to hurt themselves. Because of side effects, providers "need to take a balanced view of the likely benefits and harm of lithium in the individual patient," researchers said. The findings appeared online in BMJ.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health